it is now a standard therapy for advanced cutaneous t-cell lymphoma and shows promise in the treatment of two autoimmune disorders , pemphigus vulgaris and progressive systemic sclerosis ( scleroderma ) .
C0004364
autoimmune disorders
C0011644
scleroderma